Alexander Pasternak

This inventor holds 59 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 35 EPO patents, primarily in IDO Inhibitors (CPC class A61K). Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Other. Active years: 2000-2025.

USPTO Granted Patents = 59 (Patent Applications = 9)

% Patents Active = 83.1

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 35 (Patent Applications = 30)

Average Co-Inventor Count = 6.6

ph-index = 7

Forward Citations = 168(Granted Patents)

Forward Citations (Not Self Cited) = 96(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Princeton, NJ (US) (2000 - 2021)
Jamaica Plain, MA (US) (2022 - 2024)

Company Filing History:

42 out of 2,405

Merck Sharp + Dohme Corp.

1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Indoleamine 2,3-Dioxygenase

Metallo-Beta-Lactamase

Bicyclo Compounds

Pyrazole Compounds

Piperazine Amides

Chromane Monobactam

Beta-Tetrazolyl-Propionic Acids

Renal Outer Medullary Potassium Channel

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264134 - Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-01),

2. 12152019 - Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-11-26),

3. 12091405 - Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-09-17),

4. 12065438 - Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors (2024-08-20),

5. 11992489 - Substituted tetrahydroquinoline compounds as indoleamine 2,3-dioxygenase inhibitors (2024-05-28),

6. 11478461 - [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-10-25),

7. 11433055 - Chromane monobactam compounds for the treatment of bacterial infections (2022-09-06),

8. 11352320 - Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-06-07),

9. 11267786 - [3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-03-08),

10. 11207312 - Metallo-beta-lactamase inhibitors and methods of use thereof (2021-12-28),

11. 10544130 - Metallo-beta-lactamase inhibitors (2020-01-28),

12. 10227331 - Metallo-β-lactamase inhibitors (2019-03-12),

13. 10221163 - Metallo-beta-lactamase inhibitors (2019-03-05),

14. 10208064 - Inhibitors of the renal outer medullary potassium channel (2019-02-19),

15. 10160751 - Inhibitors of the renal outer medullary potassium channel (2018-12-25),

Title: Alexander Pasternak - Innovative Inventor from Princeton

Introduction: Alexander Pasternak is a renowned inventor based in Princeton, NJ, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Alexander Pasternak holds several patents in the areas of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Alexander Pasternak has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Alexander Pasternak has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Alexander Pasternak's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers, making him a true pioneer in the world of technology and science.